The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Energy increased 2
SANDOSTATIN LAR DEPOT Excessive cerumen production 2
SANDOSTATIN LAR DEPOT Exposure via father 2
SANDOSTATIN LAR DEPOT Extrasystoles 2
SANDOSTATIN LAR DEPOT Eye colour change 2
SANDOSTATIN LAR DEPOT Eye discharge 2
SANDOSTATIN LAR DEPOT Eye infection 2
SANDOSTATIN LAR DEPOT Eye pruritus 2
SANDOSTATIN LAR DEPOT Eyelid disorder 2
SANDOSTATIN LAR DEPOT Facial paralysis 2
SANDOSTATIN LAR DEPOT Feeling of despair 2
SANDOSTATIN LAR DEPOT Frostbite 2
SANDOSTATIN LAR DEPOT Gallbladder injury 2
SANDOSTATIN LAR DEPOT Gastric neoplasm 2
SANDOSTATIN LAR DEPOT Gastrinoma 2
SANDOSTATIN LAR DEPOT Gastroenteritis salmonella 2
SANDOSTATIN LAR DEPOT Gastrointestinal carcinoma 2
SANDOSTATIN LAR DEPOT Gastrointestinal haemorrhage 2
SANDOSTATIN LAR DEPOT Gastrointestinal motility disorder 2
SANDOSTATIN LAR DEPOT Gastrointestinal necrosis 2

Total Records: 2,045     Number of Pages: 103